Fundz
Back to SEC Filings
10-QMEDIUM RiskDETERIORATING

Elevance Health, Inc.

www.elevancehealth.com
Filed: Apr 22, 2026 CIK: 0001156039Health Care
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

Elevance Health shows mixed Q1 2026 performance with declining profitability despite revenue growth. Net income dropped 19.4% year-over-year while operating expenses surged significantly, indicating margin compression and operational challenges in the health insurance business.

Red Flags Detected (6)

Net income declined 19.4% from $2.18B to $1.76B year-over-year

Operating expenses jumped 19.4% from $5.3B to $6.33B

Medical claims payable increased 7.8% to $18.4B indicating rising medical costs

3 more red flags detected

Key Takeaways

Revenue growth of 1.5% to $49.5B demonstrates stable top-line performance

Benefit ratio deterioration suggests challenges in medical cost management

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateApr 22, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence75%
Red Flags6

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings